Correlation Between Unity Biotechnology and Adaptimmune Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Adaptimmune Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Adaptimmune Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unity Biotechnology and Adaptimmune Therapeutics Plc, you can compare the effects of market volatilities on Unity Biotechnology and Adaptimmune Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Adaptimmune Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Adaptimmune Therapeutics.
Diversification Opportunities for Unity Biotechnology and Adaptimmune Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Unity and Adaptimmune is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Adaptimmune Therapeutics Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptimmune Therapeutics and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Adaptimmune Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptimmune Therapeutics has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Adaptimmune Therapeutics go up and down completely randomly.
Pair Corralation between Unity Biotechnology and Adaptimmune Therapeutics
Considering the 90-day investment horizon Unity Biotechnology is expected to under-perform the Adaptimmune Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Unity Biotechnology is 2.14 times less risky than Adaptimmune Therapeutics. The stock trades about -0.22 of its potential returns per unit of risk. The Adaptimmune Therapeutics Plc is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 74.00 in Adaptimmune Therapeutics Plc on August 28, 2024 and sell it today you would lose (4.00) from holding Adaptimmune Therapeutics Plc or give up 5.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unity Biotechnology vs. Adaptimmune Therapeutics Plc
Performance |
| Timeline |
| Unity Biotechnology |
| Adaptimmune Therapeutics |
Unity Biotechnology and Adaptimmune Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unity Biotechnology and Adaptimmune Therapeutics
The main advantage of trading using opposite Unity Biotechnology and Adaptimmune Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Adaptimmune Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptimmune Therapeutics will offset losses from the drop in Adaptimmune Therapeutics' long position.| Unity Biotechnology vs. Eliem Therapeutics | Unity Biotechnology vs. HCW Biologics | Unity Biotechnology vs. Scpharmaceuticals | Unity Biotechnology vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |